Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial to Study the Efficacy and Safety of Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

NCT01218230 is registered in ClinicalTrials.gov with L.V. Prasad Eye Institute as lead sponsor.

NCT NCT01218230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial to Study the Efficacy and Safety of Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia
Lead sponsor
L.V. Prasad Eye Institute
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2010
Completion date
July 31, 2012
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopic choroidal neovascular membrane